Dynavax Technologies reported $4.32M in Interest Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Adma Biologics ADMA:US USD 7.24K 4.97K
Biogen BIIB:US USD 49.9M 26M
BioMarin Pharmaceutical BMRN:US USD 8.71M 3.71M
Chimerix CMRX:US USD 2.74M 2.54M
Dynavax Technologies DVAX:US USD 4.32M 1.76M
Idera Pharmaceuticals IDRA:US USD 111K 69K
Nektar Therapeutics NKTR:US USD 3.13M 1.08M
Pfizer PFE:US USD 137M 67M
Sarepta Therapeutics SRPT:US USD 9.13M 4.35M
Vertex Pharmaceuticals VRTX:US USD 86M 39.8M